Company news
ValiRx PLC news in 2017
ValiRx PLC's news releases, calls and decks from 2017, newest first.
Final Loan Note Conversion and Issue of Equity
December 27, 2017
Warrant Exercise
December 20, 2017
re: VAL201 Clinical Trials
December 18, 2017
ValiSeek Clinical Development Update
December 12, 2017
Loan Note Conversion and Issue of Equity
December 11, 2017
Shareholder Circular and Notice of General Meeting
December 6, 2017
Yorkville CLN Conversion
November 15, 2017
Notification of US Patent Allowance
October 11, 2017
VAL201 update
September 20, 2017
Hardman Research: GeneICE and VAL101 progress
September 13, 2017
GeneICE & VAL101 Update
September 7, 2017
Convertible Loan Facility
August 11, 2017
Conversion of Loan Note
August 2, 2017
Licencing Agreement
July 28, 2017
Formation of & Appointments to an Advisory Board
June 22, 2017
ValiSeek Development Update - Recruitment Closes
June 15, 2017
Hardman Research: Developing novel cancer therapies
May 31, 2017
Notification of Australian Patent allowance
May 24, 2017
Re: SHARES Magazine Supplement on ValiRx website
April 27, 2017
Placing to raise £1.16m and Proposed Subscription
March 1, 2017
Publication of Peer-Reviewed Articles on VAL401
February 28, 2017
CLINICAL TRIAL UPDATE - Positive VAL201 Results
January 11, 2017